Anakinra: efficacy in the management of fever during neutropenia and mucositis in autologous stem cell transplantation (AFFECT-2)—study protocol for a multicenter randomized double-blind placebo-controlled trial

BACKGROUND: Since decades, fever and infections have been the most important complications of intensive chemotherapy and hematopoietic stem cell transplantation (HSCT) in the treatment of hematologic malignancies. Neutropenia has long been considered to be the most important risk factor for these co...

Descripción completa

Detalles Bibliográficos
Autores principales: de Mooij, Charlotte E. M., van Groningen, Lenneke F. J., de Haan, Anton F. J., Biemond, Bart J., Bakker, Martijn, van der Velden, Walter J. F. M., Blijlevens, Nicole M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681989/
https://www.ncbi.nlm.nih.gov/pubmed/33225965
http://dx.doi.org/10.1186/s13063-020-04847-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681989/
https://www.ncbi.nlm.nih.gov/pubmed/33225965
http://dx.doi.org/10.1186/s13063-020-04847-5

Ejemplares similares